15% of Americans have ever taken the drugs, up from 6% in 2024. The percentage of American adults who are currently taking a GLP-1 drug for weight loss is 11%, according to a new survey from Gallup.
Matt Novak is a reporter at Gizmodo. He covers a range of topics including technology, politics, and public policy, with a particular interest in the history of technology and its implications for the future. Novak has been featured in various outlets such as Vox, Yahoo News, and Forbes, contributing his insights on themes like artificial intelligence, aviation, and legal affairs.
















